Keyphrases
Abstinence
41%
Addiction Services
30%
Alcohol
60%
Alcohol Dependence
51%
Alcohol Problems
47%
Alcohol-related
33%
Behavior Therapy
29%
Birmingham
31%
Birmingham UK
38%
BUP-XR
31%
Buprenorphine
47%
Confidence Interval
33%
Contingency Management
52%
Cost-effectiveness
46%
Drug Intervention
31%
Drug Treatment
93%
Drug Treatment Services
33%
Drug Use
76%
Drug Users
67%
Drug-related Problems
27%
Economic Evaluation
40%
Emergency Department
31%
Extended-release Buprenorphine
31%
Heroin
53%
Heroin Use
47%
Heroin Users
32%
Illicit Drugs
39%
Intervention Program
31%
Liver Transplantation
42%
Methadone
42%
Naloxone
34%
Naltrexone
31%
Narcotics Anonymous
31%
Network Centric Therapy
27%
Offenders
43%
Opiate Dependence
42%
Opiate Substitution Treatment
56%
Opioid Dependence
38%
Opioid Use Disorder
34%
Psychosocial Intervention
60%
Randomized Controlled Trial
79%
Social Behavior
27%
Social Network Intervention
31%
Social Networks
41%
Substance Use
32%
Take-home Naloxone
42%
Treatment Engagement
26%
Treatment Services
39%
United Kingdom
28%
Young People
34%
Medicine and Dentistry
Abstinence
43%
Acamprosate
21%
Addictive Behavior
28%
Adverse Event
11%
Alcohol Consumption
37%
Alcohol Liver Disease
13%
Alcohol Withdrawal Syndrome
17%
Alcohol-Related Liver Disease
21%
Alcoholic Polyneuropathy
61%
Amphetamine Derivative
16%
Arm
17%
Assertive Community Treatment
21%
Buprenorphine
35%
Clinical Management
14%
Clinician
19%
Cluster Randomized Trial
21%
Cost-Effectiveness Analysis
39%
Diamorphine
64%
Disease
10%
Diseases
30%
Drug Therapy
43%
Drug Use
31%
Electroconvulsive Therapy
10%
Glycemic
21%
Harm Reduction
11%
Health Care Cost
35%
Intervention Trial
11%
Intoxication
11%
Kidney Allograft
21%
Lifespan
12%
Lifestyle Intervention
22%
Liver Disease
11%
Liver Transplantation
31%
Mental Health
14%
Methadone
25%
Naloxone
21%
Naltrexone
31%
Opiate Substitution Treatment
15%
Opioid Abuse
36%
Opioid Dependence
21%
Patient Referral
13%
Physician
10%
Placebo
15%
Psychiatry
10%
Quality Adjusted Life Year
11%
Quality of Life
12%
Randomized Controlled Trial
100%
Relapse Prevention
44%
Substance Abuse
14%
Systematic Review
21%